Onc

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech taps Sobi CEO Guido Oelkers as its next chief executive, with a mandate to turn a deep oncology pipeline into multiple approved products by 2030.

ONC marks universal EHR adoption and one billion TEFCA health records exchanged in inaugural Coordinator's Quarterly

ONC's first-ever Coordinator's Quarterly declares universal EHR adoption across the U.S. healthcare ecosystem and announces TEFCA has exchanged one billion reco

From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

The Uber of Healthcare: How OverbookMD is Using Data and Tech to Redefine Patient Care

In today’s world, where instant delivery and ride-sharing are everyday norms, healthcare access still lags behind. Patients now wait an average of 31 days to see a specialist in major U.S. cities—a 19 percent jump since 2022—according to AMN Healthcare’s 2025 survey. The stakes are high: delays can lead to worsening conditions, increased ER visits,…

Debunking Sepsis Myths – Episode 1

In the first episode of The Michael Rothman podcast, we address misconceptions about sepsis in healthcare. Although it’s often claimed that sepsis accounts for nearly a third of hospital deaths, many of these deaths are linked to chronic conditions with sepsis as a secondary factor. The frequently cited statistic that delays in treating sepsis increase…

Inside Oncology Drug Development: Overcoming Resistance with Science

Scientists are racing to solve the cancer cell adaptation problem that renders even cutting-edge therapies ineffective over time

Growing the Future of Cancer Research: Inside the Promise of Organoids

Miniature lab-grown tissues are poised to revolutionize how researchers predict which cancer treatments will work for individual patients

Shaping the Future of Cancer Care Through Immuno-Oncology

Combination therapies and emerging cell-based treatments are reshaping how oncologists tackle cancer at the cellular level

Evolving Biomarkers: Charting the Future of Precision Medicine

The shift from broad treatments to targeted therapies hinges on identifying which patients will actually benefit from specific drugs

Pioneering Strategies to Unlocking the Potential of KRAS

Scientists are racing to overcome resistance mechanisms in newly approved KRAS therapies targeting the majority of difficult-to-treat cancers

Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation

Smaller pharma companies are accelerating drug development by leveraging advanced data analytics to streamline trials and regulatory pathways

Empathy & Innovation in Leadership with Nadine Hauf | Ep. 26 | Growthwell with Josh Byrd

Leaders in healthcare discover that combining empathy with innovation drives employee engagement and better patient outcomes in complex systems

The Road to the Dallas 100™ – Free Range Concepts

From college roommates to hospitality innovators, these cofounders built DFW's most memorable restaurant and entertainment concepts

The Trucking Industry Needs a Fitness Overhaul to Jumpstart a Trucking Health Revolution

Drivers facing a 16-year life expectancy gap reveal why the industry must prioritize wellness alongside productivity

Rising Cancer Diagnoses in Young Adults: Lifestyle Changes and Early Screenings can Lower Risks

Early interventions and lifestyle adjustments offer young adults a fighting chance against a disease that's striking earlier than ever before

Selecting and Finding the Best Healthcare Physicians Requires a Roadmap That Leads to Trust and Accessibility

Patients struggle to find trustworthy physicians in an oversaturated market where unnecessary procedures remain rampant